CytRx Laboratories, Inc. RNAi Subsidiary, RXi Pharmaceuticals, Names Vice President of Pharmaceutical Development

Published: Mar 08, 2007

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation’s (NASDAQ:CYTR) majority-owned subsidiary, Worcester, Mass.-based RXi Pharmaceuticals Corporation (RXi), today announced that Pamela A. Pavco, Ph.D., has joined RXi as Vice President of Pharmaceutical Development.

Back to news